Jul 20, 2023 · Rachel Layman, MD, summarizes how to dose CDK4/6 inhibitors in different clinical settings.

Apr 14, 2023 · CDK4/6 inhibitors are a class of drugs that target particular enzymes, called CDK4 and CDK6. CDK stands for cyclin-dependent kinase, and it is an enzyme that is important for cell division. …

*The intent of this tool is to display dose adjustments for CDK4/6 inhibitor-induced neutropenia, which vary greatly from those for chemotherapy-related neutropenia. For other hematologic adverse …

Jun 5, 2026 · The purpose of this study is to generate evidence on an alternative dosing strategy for CDK4/6 inhibitors to help more patients with Metastatic Breast Cancer (MBC) (age ≥ 65 years) …

See information about popular Cdk4 6 Inhibitors, including the conditions they treat and alternatives available with or without insurance.

Each oral targeted therapy has a specific schedule that should be followed for safety and efficacy. Your cancer team may modify the dose or schedule based on lab results or side effects. Your cancer team …

Sep 25, 2025 · Panelists discuss how FDA-approved CDK4/6 inhibitors are used in early breast cancer (abemaciclib and ribociclib with different trial designs and dosing regimens) and metastatic breast …

Apr 8, 2026 · Learn how CDK4/6 inhibitor schedules vary and how pharmacists boost adherence, manage nausea, labs, QTc, and drug interactions.

Jan 29, 2026 · CDK4/6 inhibitors are a class of medicines used to treat certain types of hormone receptor-positive, HER2-negative breast cancer. These medicines interrupt the process through …

Together with their treating physician, participants will choose the CDK4/6 inhibitor (palbociclib or ribociclib) and which endocrine therapy (aromatase inhibitor or fulvestrant) of their choice but will be …